Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background & Aims</h3><p>PreS mutants of HBV have been reported to be associated with hepatocellular carcinoma (HCC). We conducted a longitudinal study of the role of HBV preS mutations on development of HCC, particularly in chronic hepatitis B (CHB) patients having low HBV DNA or ALT levels, and investigated effects of secretion‐defective preS2 deletion mutant (preS2ΔMT) on hepatocyte damage <i>in vitro</i> and liver fibrosis <i>in vivo</i>. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Approach and Results</h3><p>Association of preS mutations with HCC in 343 CHB patients was evaluated by retrospective case‐control follow‐up study. Effects of preS2ΔMT on HBsAg retention, ER stress, calcium accumulation, mitochondrial dysfunction, and liver fibrosis were examined. Multivariate analysis revealed significant association of preS mutations with HCC (HR: 3.210, 95% CI: 1.072‐9.613; p=0.037) including cases with low HBV DNA or ALT levels (HR: 2.790, 95% CI: 1.133‐6.873; p=0.026). Antiviral therapy reduced HCC risk, including cases with preS mutations. preS2ΔMT expression promoted HBsAg retention in ER and unfolded protein response (UPR). TEM examination, MitoTracker staining, real‐time ATP assay, and calcium staining of preS2ΔMT‐expressing cells revealed aberrant ER and mitochondrial ultrastructure, reduction of mitochondrial membrane potential and ATP production, and calcium overload. Serum HBV secretion levels were ~100‐fold lower in preS2ΔMT‐infected hu‐FRG mice than in WT HBV‐infected mice. preS2ΔMT‐infected mice displayed upregulation of UPR and caspase‐3, and enhanced liver fibrosis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>PreS mutations were significantly associated with HCC development in CHB patients, including those low HBV DNA or ALT levels. Antiviral therapy reduced HCC occurrence in CHB patients, including those with preS mutations. Intracellular accumulation of mutated HBsAg induced or promoted ER stress, calcium overload, mitochondrial dysfunction, impaired energy metabolism, liver fibrosis, and HCC.</p></section>

HBV Pres2 Transactivates FOXP3 Expression in Malignant Hepatocytes

Hepatitis B Virus Protein Pres2 Potentially Promotes Hcc Development Via Its Transcriptional Activation of Htert

HBV Pres2 Promotes the Expression of TAZ Via Mirna-338-3p to Enhance the Tumorigenesis of Hepatocellular Carcinoma

In Vitro Transfection Of The Hepatitis B Virus Pres2 Gene Into The Human Hepatocarcinoma Cell Line Hepg2 Induces Upregulation Of Human Telomerase Reverse Transcriptase

HBV preS Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Upregulating Inflammatory Signaling

Hepatitis B Virus PreS1 Facilitates Hepatocellular Carcinoma Development by Promoting Appearance and Self-Renewal of Liver Cancer Stem Cells.

HBV Pres Mutations Promote Hepatocarcinogenesis by Inducing Endoplasmic Reticulum Stress and Up-Regulating Inflammatory Signaling

Blockade of preS2 down-regulates the apoptosis of HepG2.2.15 cells induced by TRAIL.

HBV Rewires Liver Cancer Signaling by Altering PP2A Complexes

Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase

HBV Suppresses ZHX2 Expression to Promote Proliferation of HCC Through Mir-155 Activation

PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation

Regulatory Effect of HBV Integrated Fragment on PCNA Promoter.

Hepatitis B Virus X Protein Promotes P3 Transcript Expression of the Insulin‐like Growth Factor 2 Gene Via Inducing Hypomethylation of P3 Promoter in Hepatocellular Carcinoma

Hepatitis B virus X protein upregulates DNA methyltransferase 3A/3B and enhances SOCS-1CpG island methylation.

SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters

Hepatitis B Virus X Protein–elevated MSL2 Modulates Hepatitis B Virus Covalently Closed Circular DNA by Inducing Degradation of APOBEC3B to Enhance Hepatocarcinogenesis

Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development

Hepatitis B Virus X Protein Promotes Human Hepatoma Cell Growth Via Upregulation of Transcription Factor AP2α and Sphingosine Kinase 1

Hepatitis B Virus S Promoter Deletion in Hepatocellular Carcinoma

Up-regulation of S100A4 Expression by HBx Protein Promotes Proliferation of Hepatocellular Carcinoma Cells and Its Correlation with Clinical Survival.